Researchers have demonstrated that ACE inhibitors could improve endothelial dysfunction by enhancing the release of nitric oxide from endothelial cells to induce vasodilation53–55 and the capability of inhibiting ACE activity with an HPD may explain the improvement in FMD. The gene discussed is ACE; the disease is endothelial dysfunction.